SYRE R&D to Revenue

Spyre Therapeutics Inc · R&D to Revenue

SYRE logo

SYRE R&D to Revenue

Latest reported0.00%
SYRE FY R&D/Revenue (0.00% → 0.00%)
High-resolution chart · PNG

SYRE r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
0%
0%
10,102.0316%
2,515.1997%
304.5467%
0%
0%
944.4187%
438.3285%
392.0268%
188.2169%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.